Beta Bionics, Inc. logo BBNX - Beta Bionics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 6
HOLD 2
SELL 0
STRONG
SELL 0
| PRICE TARGET: $24.00 DETAILS
HIGH: $30.00
LOW: $16.00
MEDIAN: $25.00
CONSENSUS: $24.00
UPSIDE: 32.74%

Stock News

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

New York, New York--(Newsfile Corp. - October 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased Beta Bionics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Oct 07, 2026 01:14 PM • newsfilecorp.com (Hide legal announcements)
Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming November 3, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) securities between July 30, 2025 and February 24, 2026 inclusive (the “Class Period”).

Oct 07, 2026 11:30 AM • globenewswire.com (Hide legal announcements)
Kaplan Fox Alerts Beta Bionics, Inc. (BBNX) Investors to a Securities Fraud Lawsuit - Lead Plaintiff Deadline is November 3, 2026

Kaplan Fox Alerts Beta Bionics, Inc. (BBNX) Investors to a Securities Fraud Lawsuit - Lead Plaintiff Deadline is November 3, 2026

New York, New York--(Newsfile Corp. - October 7, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Beta Bionics and have suffered losses, you may CLICK HERE to contact us.

Oct 07, 2026 10:15 AM • newsfilecorp.com (Hide legal announcements)
BBNX UPCOMING DEADLINE: Levi & Korsinsky Alerts Beta Bionics, Inc. Stockholders of Securities Class Action - Contact the Firm

BBNX UPCOMING DEADLINE: Levi & Korsinsky Alerts Beta Bionics, Inc. Stockholders of Securities Class Action - Contact the Firm

Alert: Beta Bionics shares slid from a Class Period high of $31.99 to under $9 across three disclosure events, as a securities class action contends the Company minimized an FDA Form 483 citing more than 18,000 unreported iLet complaints. NEW YORK, Oct. 7, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in Beta Bionics, Inc. (NASDAQ: BBNX) that a securities class action was filed on behalf of shareholders who purchased securities between July 30, 2025 and February 24, 2026.

Oct 07, 2026 06:09 AM • prnewswire.com (Hide legal announcements)
Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline – Contact the Firm Before November 3, 2026

Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline – Contact the Firm Before November 3, 2026

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in Beta Bionics and have suffered losses, you may CLICK HERE to contact us.

Oct 07, 2026 05:00 AM • globenewswire.com (Hide legal announcements)
Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance

Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance

SAN FRANCISCO, Oct. 7, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026. The lawsuit follows a series of surprise revelations about the FDA's concerns over company's automated insulin delivery system ("iLet"), each of which sent the price of Beta Bionics shares sharply lower.

Oct 07, 2026 04:12 AM • prnewswire.com (Hide legal announcements)
BBNX Investor Reminder: BFA Law Reminds Beta Bionics Investors that Lost Money when Stock Dropped 37% of the Pending Securities Class Action and Upcoming Deadline

BBNX Investor Reminder: BFA Law Reminds Beta Bionics Investors that Lost Money when Stock Dropped 37% of the Pending Securities Class Action and Upcoming Deadline

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (NASDAQ:BBNX) and certain of the company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in Beta Bionics, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/beta-bionics-class-action-lawsuit.

Oct 07, 2026 02:18 AM • globenewswire.com (Hide legal announcements)
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK and NEW ORLEANS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX) of a class action securities lawsuit.

Oct 06, 2026 05:37 PM • globenewswire.com (Hide legal announcements)
BBNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

BBNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Beta Bionics (BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Beta Bionics between July 30, 2025 and February 24, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 6, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) and reminds investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Oct 06, 2026 02:35 PM • newsfilecorp.com (Hide legal announcements)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Oct 06, 2026 12:44 PM • globenewswire.com (Hide legal announcements)
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., October 6, 2026. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), of the important November 3, 2026 lead plaintiff deadline.

Oct 06, 2026 11:13 AM • globenewswire.com (Hide legal announcements)
Kaplan Fox Advises Investors of Beta Bionics, Inc. (BBNX) of an Upcoming Securities Class Action Deadline on November 3, 2026

Kaplan Fox Advises Investors of Beta Bionics, Inc. (BBNX) of an Upcoming Securities Class Action Deadline on November 3, 2026

New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Beta Bionics and have suffered losses, you may CLICK HERE to contact us.

Oct 06, 2026 10:00 AM • newsfilecorp.com (Hide legal announcements)
BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

SAN FRANCISCO, Oct. 6, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026. The lawsuit follows a series of surprise revelations about the FDA's concerns over company's automated insulin delivery system ("iLet"), each of which sent the price of Beta Bionics shares sharply lower.

Oct 06, 2026 08:50 AM • prnewswire.com (Hide legal announcements)
BBNX Shareholder Alert: Beta Bionics, Inc. Securities Class Action Lawsuit – Investors Should Contact SueWallSt

BBNX Shareholder Alert: Beta Bionics, Inc. Securities Class Action Lawsuit – Investors Should Contact SueWallSt

Time-sensitive notice: the lawsuit asserts that Beta Bionics management described an FDA Form 483 and a subsequent FDA Warning Letter as a "very benign" difference in interpretation of reporting rules, when the agency had allegedly identified systemic quality-management and patient-safety non-conformities. Time-sensitive notice: the lawsuit asserts that Beta Bionics management described an FDA Form 483 and a subsequent FDA Warning Letter as a "very benign" difference in interpretation of reporting rules, when the agency had allegedly identified systemic quality-management and patient-safety non-conformities.

Oct 06, 2026 08:23 AM • globenewswire.com (Hide legal announcements)
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) between June 30, 2025 and February 24, 2026, inclusive. Should You Join The Beta Bionics Class Action Lawsuit : Do you, or did you, own shares of Beta Bionics, Inc. (NASDAQ: BBNX)?

Oct 06, 2026 04:36 AM • globenewswire.com (Hide legal announcements)
BBNX Stock Notice: Beta Bionics Stock Plummeted 37% after Medical Device Safety Issues Disclosed - Securities Fraud Class Action Filed

BBNX Stock Notice: Beta Bionics Stock Plummeted 37% after Medical Device Safety Issues Disclosed - Securities Fraud Class Action Filed

A securities fraud class action lawsuit has been filed on behalf of Beta Bionics investors after its stock plummeted over 37% because Beta Bionics allegedly misled investors about the safety, efficacy, and commercial success of its iLet medical device, potentially violating the federal securities laws. NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP  announces that a class action lawsuit has been filed against Beta Bionics, Inc. (NASDAQ:BBNX) and certain of the company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

Oct 06, 2026 01:36 AM • prnewswire.com (Hide legal announcements)

Price Targets